HomeTGTX • NASDAQ
add
TG Therapeutics Inc common stock
Previous close
$14.25
Day range
$13.74 - $14.35
Year range
$6.46 - $35.67
Market cap
2.16B USD
Avg Volume
2.59M
P/E ratio
163.83
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 43.97M | 54,863.75% |
Operating expense | 48.60M | -6.78% |
Net income | -14.42M | 72.80% |
Net profit margin | -32.79 | 99.95% |
Earnings per share | -0.10 | 74.36% |
EBITDA | -12.45M | 76.06% |
Effective tax rate | -2.78% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 217.51M | 34.53% |
Total assets | 329.59M | 70.27% |
Total liabilities | 169.08M | 25.26% |
Total equity | 160.50M | — |
Shares outstanding | 144.78M | — |
Price to book | 12.61 | — |
Return on assets | -9.45% | — |
Return on capital | -11.42% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -14.42M | 72.80% |
Cash from operations | -13.21M | 44.66% |
Cash from investing | -44.76M | -375.09% |
Cash from financing | -1.00K | -102.04% |
Net change in cash | -57.97M | -667.56% |
Free cash flow | -13.80M | -144.48% |
About
Founded
1993
Headquarters
Website
Employees
264